Marken, a pharmaceutical supply chain organization, has completed its fully owned depot in Moscow for the clinical and commercial pharmaceutical drug storage, clinical trial services, and distribution. The depot is set to open next year.

Located in a new building, the facility has dedicated space for drug product storage, late-stage labeling, returns, and destruction for rejected goods and deliver typical services, including temperature-controlled storage at all ranges from -20 and 2-8 degrees to controlled room temperature, plus liquid nitrogen storage capabilities.

Like all Marken depots, the new Moscow facility is managed by the company's global inventory system, Solo, which offers real-time access to live data that tracks the conditions inside the depot as well as the disposition of materials. It also connects to Marken's Maestro system, which books and tracks all shipments into and out of the depot on a real-time basis.

Source: Marken